BIO-UV GROUP SAS (ALTUV.PA) Stock Fundamental Analysis
Europe - Euronext Paris - EPA:ALTUV - FR0013345493 - Common Stock
1.586 EUR
+0.02 (+1.02%)
ALTUV gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 108 industry peers in the Machinery industry. Both the profitability and the financial health of ALTUV get a neutral evaluation. Nothing too spectacular is happening here. ALTUV has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
ALTUV had positive earnings in the past year.
ALTUV had a positive operating cash flow in the past year.
ALTUV had positive earnings in each of the past 5 years.
Of the past 5 years ALTUV 4 years had a positive operating cash flow.
1.2 Ratios
The Return On Assets of ALTUV (1.36%) is worse than 62.96% of its industry peers.
The Return On Equity of ALTUV (2.41%) is worse than 64.81% of its industry peers.
ALTUV's Return On Invested Capital of 2.84% is on the low side compared to the rest of the industry. ALTUV is outperformed by 68.52% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ALTUV is significantly below the industry average of 8.99%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.36% | ||
| ROE | 2.41% | ||
| ROIC | 2.84% |
ROA(3y)1.16%
ROA(5y)1.09%
ROE(3y)2.65%
ROE(5y)2.43%
ROIC(3y)3.91%
ROIC(5y)3.06%
1.3 Margins
Looking at the Profit Margin, with a value of 2.64%, ALTUV is in line with its industry, outperforming 45.37% of the companies in the same industry.
In the last couple of years the Profit Margin of ALTUV has declined.
ALTUV has a Operating Margin (5.93%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of ALTUV has grown nicely.
The Gross Margin of ALTUV (38.14%) is comparable to the rest of the industry.
ALTUV's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.93% | ||
| PM (TTM) | 2.64% | ||
| GM | 38.14% |
OM growth 3Y21.79%
OM growth 5YN/A
PM growth 3Y-66.23%
PM growth 5YN/A
GM growth 3Y1.74%
GM growth 5Y3.01%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ALTUV is destroying value.
ALTUV has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, ALTUV has more shares outstanding
ALTUV has a better debt/assets ratio than last year.
2.2 Solvency
ALTUV has an Altman-Z score of 1.44. This is a bad value and indicates that ALTUV is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.44, ALTUV is doing worse than 62.96% of the companies in the same industry.
The Debt to FCF ratio of ALTUV is 7.69, which is on the high side as it means it would take ALTUV, 7.69 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 7.69, ALTUV perfoms like the industry average, outperforming 44.44% of the companies in the same industry.
A Debt/Equity ratio of 0.39 indicates that ALTUV is not too dependend on debt financing.
ALTUV has a Debt to Equity ratio (0.39) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.39 | ||
| Debt/FCF | 7.69 | ||
| Altman-Z | 1.44 |
ROIC/WACC0.41
WACC6.98%
2.3 Liquidity
ALTUV has a Current Ratio of 2.05. This indicates that ALTUV is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of ALTUV (2.05) is better than 78.70% of its industry peers.
ALTUV has a Quick Ratio of 1.31. This is a normal value and indicates that ALTUV is financially healthy and should not expect problems in meeting its short term obligations.
ALTUV's Quick ratio of 1.31 is fine compared to the rest of the industry. ALTUV outperforms 75.93% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.05 | ||
| Quick Ratio | 1.31 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 195.24% over the past year.
ALTUV shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -64.42% yearly.
Looking at the last year, ALTUV shows a decrease in Revenue. The Revenue has decreased by -7.99% in the last year.
ALTUV shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.65% yearly.
EPS 1Y (TTM)195.24%
EPS 3Y-64.42%
EPS 5YN/A
EPS Q2Q%167.3%
Revenue 1Y (TTM)-7.99%
Revenue growth 3Y5.76%
Revenue growth 5Y14.65%
Sales Q2Q%-7.98%
3.2 Future
The Earnings Per Share is expected to grow by 14.51% on average over the next years. This is quite good.
Based on estimates for the next years, ALTUV will show a small growth in Revenue. The Revenue will grow by 3.57% on average per year.
EPS Next Y-29.92%
EPS Next 2Y0.06%
EPS Next 3Y14.51%
EPS Next 5YN/A
Revenue Next Year0%
Revenue Next 2Y2.74%
Revenue Next 3Y3.57%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 22.66, the valuation of ALTUV can be described as rather expensive.
The rest of the industry has a similar Price/Earnings ratio as ALTUV.
ALTUV's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.31.
With a Price/Forward Earnings ratio of 15.40, ALTUV is valued correctly.
ALTUV's Price/Forward Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.59, ALTUV is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 22.66 | ||
| Fwd PE | 15.4 |
4.2 Price Multiples
ALTUV's Enterprise Value to EBITDA ratio is in line with the industry average.
79.63% of the companies in the same industry are more expensive than ALTUV, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.17 | ||
| EV/EBITDA | 9.05 |
4.3 Compensation for Growth
A more expensive valuation may be justified as ALTUV's earnings are expected to grow with 14.51% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.06%
EPS Next 3Y14.51%
5. Dividend
5.1 Amount
ALTUV has a Yearly Dividend Yield of 2.50%.
Compared to an average industry Dividend Yield of 2.47, ALTUV pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.40, ALTUV has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.5% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DP0%
EPS Next 2Y0.06%
EPS Next 3Y14.51%
EPA:ALTUV (11/28/2025, 7:00:00 PM)
1.586
+0.02 (+1.02%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)
Earnings (Next)
Inst Owners6.2%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap22.44M
Revenue(TTM)37.81M
Net Income(TTM)996.80K
Analysts86.67
Price Target3.06 (92.94%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.5% |
Yearly Dividend0.06
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)40%
EPS NY rev (3m)-64.96%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-12.2%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 22.66 | ||
| Fwd PE | 15.4 | ||
| P/S | 0.59 | ||
| P/FCF | 8.17 | ||
| P/OCF | 4.71 | ||
| P/B | 0.54 | ||
| P/tB | 4.38 | ||
| EV/EBITDA | 9.05 |
EPS(TTM)0.07
EY4.41%
EPS(NY)0.1
Fwd EY6.49%
FCF(TTM)0.19
FCFY12.24%
OCF(TTM)0.34
OCFY21.25%
SpS2.67
BVpS2.93
TBVpS0.36
PEG (NY)N/A
PEG (5Y)N/A
Graham Number2.15
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.36% | ||
| ROE | 2.41% | ||
| ROCE | 3.87% | ||
| ROIC | 2.84% | ||
| ROICexc | 2.84% | ||
| ROICexgc | 7.55% | ||
| OM | 5.93% | ||
| PM (TTM) | 2.64% | ||
| GM | 38.14% | ||
| FCFM | 7.26% |
ROA(3y)1.16%
ROA(5y)1.09%
ROE(3y)2.65%
ROE(5y)2.43%
ROIC(3y)3.91%
ROIC(5y)3.06%
ROICexc(3y)4.12%
ROICexc(5y)3.44%
ROICexgc(3y)16.95%
ROICexgc(5y)12.95%
ROCE(3y)5.34%
ROCE(5y)4.18%
ROICexgc growth 3Y38.43%
ROICexgc growth 5YN/A
ROICexc growth 3Y32.09%
ROICexc growth 5YN/A
OM growth 3Y21.79%
OM growth 5YN/A
PM growth 3Y-66.23%
PM growth 5YN/A
GM growth 3Y1.74%
GM growth 5Y3.01%
F-Score7
Asset Turnover0.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.39 | ||
| Debt/FCF | 7.69 | ||
| Debt/EBITDA | 3.38 | ||
| Cap/Depr | 79.6% | ||
| Cap/Sales | 5.35% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 99.7% | ||
| Profit Quality | 275.52% | ||
| Current Ratio | 2.05 | ||
| Quick Ratio | 1.31 | ||
| Altman-Z | 1.44 |
F-Score7
WACC6.98%
ROIC/WACC0.41
Cap/Depr(3y)64.42%
Cap/Depr(5y)89.94%
Cap/Sales(3y)4.59%
Cap/Sales(5y)6.26%
Profit Quality(3y)6416.11%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)195.24%
EPS 3Y-64.42%
EPS 5YN/A
EPS Q2Q%167.3%
EPS Next Y-29.92%
EPS Next 2Y0.06%
EPS Next 3Y14.51%
EPS Next 5YN/A
Revenue 1Y (TTM)-7.99%
Revenue growth 3Y5.76%
Revenue growth 5Y14.65%
Sales Q2Q%-7.98%
Revenue Next Year0%
Revenue Next 2Y2.74%
Revenue Next 3Y3.57%
Revenue Next 5YN/A
EBIT growth 1Y9.49%
EBIT growth 3Y28.8%
EBIT growth 5YN/A
EBIT Next Year128.57%
EBIT Next 3Y40.3%
EBIT Next 5YN/A
FCF growth 1Y112.9%
FCF growth 3Y105.52%
FCF growth 5YN/A
OCF growth 1Y18.9%
OCF growth 3Y27.9%
OCF growth 5YN/A
BIO-UV GROUP SAS / ALTUV.PA FAQ
Can you provide the ChartMill fundamental rating for BIO-UV GROUP SAS?
ChartMill assigns a fundamental rating of 4 / 10 to ALTUV.PA.
What is the valuation status for ALTUV stock?
ChartMill assigns a valuation rating of 4 / 10 to BIO-UV GROUP SAS (ALTUV.PA). This can be considered as Fairly Valued.
What is the profitability of ALTUV stock?
BIO-UV GROUP SAS (ALTUV.PA) has a profitability rating of 4 / 10.
How financially healthy is BIO-UV GROUP SAS?
The financial health rating of BIO-UV GROUP SAS (ALTUV.PA) is 4 / 10.
What is the earnings growth outlook for BIO-UV GROUP SAS?
The Earnings per Share (EPS) of BIO-UV GROUP SAS (ALTUV.PA) is expected to decline by -29.92% in the next year.